These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam. Coutinho RA; Krone WJ; Smit L; Albrecht-van Lent P; van der Noordaa J; Schaesberg W; Goudsmit J Genitourin Med; 1986 Feb; 62(1):38-43. PubMed ID: 3005159 [TBL] [Abstract][Full Text] [Related]
5. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men. Jaffe HW; Feorino PM; Darrow WW; O'Malley PM; Getchell JP; Warfield DT; Jones BM; Echenberg DF; Francis DP; Curran JW Ann Intern Med; 1985 May; 102(5):627-8. PubMed ID: 2984973 [TBL] [Abstract][Full Text] [Related]
6. Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV). Balzarini J; Mitsuya H; De Clercq E; Broder S Int J Cancer; 1986 Mar; 37(3):451-7. PubMed ID: 2419266 [TBL] [Abstract][Full Text] [Related]
7. Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS. Weber JN; McCreaner A; Berrie E; Wadsworth J; Jeffries DJ; Pinching AJ; Harris JR Genitourin Med; 1986 Jun; 62(3):177-80. PubMed ID: 3015772 [TBL] [Abstract][Full Text] [Related]
8. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Osame M; Matsumoto M; Usuku K; Izumo S; Ijichi N; Amitani H; Tara M; Igata A Ann Neurol; 1987 Feb; 21(2):117-22. PubMed ID: 2881513 [TBL] [Abstract][Full Text] [Related]
9. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). Nicholson JK; Cross GD; Callaway CS; McDougal JS J Immunol; 1986 Jul; 137(1):323-9. PubMed ID: 3011909 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus. Yarchoan R; Redfield RR; Broder S J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028 [TBL] [Abstract][Full Text] [Related]
11. Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men. Nicholson JK; McDougal JS; Jaffe HW; Spira TJ; Kennedy MS; Jones BM; Darrow WW; Morgan M; Hubbard M Ann Intern Med; 1985 Jul; 103(1):37-42. PubMed ID: 2988389 [TBL] [Abstract][Full Text] [Related]
12. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822 [TBL] [Abstract][Full Text] [Related]
13. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. McDougal JS; Kennedy MS; Sligh JM; Cort SP; Mawle A; Nicholson JK Science; 1986 Jan; 231(4736):382-5. PubMed ID: 3001934 [TBL] [Abstract][Full Text] [Related]
14. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood. Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566 [TBL] [Abstract][Full Text] [Related]
17. [Clinical and virological study of a case of infection with the HIV-LAV 2 virus]. Saimot AG; Girard PM; Brun-Vezinet F; Bartczak S; Rey MA; Coulaud JP Ann Med Interne (Paris); 1987; 138(6):419-21. PubMed ID: 2893571 [TBL] [Abstract][Full Text] [Related]
18. Altered subsets of peripheral blood lymphocytes in patients with HTLV-I associated myelopathy (HAM). Itoyama Y; Minato S; Kira J; Goto I; Sato H; Okochi K; Yamamoto N Neurology; 1988 May; 38(5):816-8. PubMed ID: 2896315 [TBL] [Abstract][Full Text] [Related]
19. Spectrum of human T-cell lymphotropic virus type III infection in children. Recognition of symptomatic, asymptomatic, and seronegative patients. Pahwa S; Kaplan M; Fikrig S; Pahwa R; Sarngadharan MG; Popovic M; Gallo RC JAMA; 1986 May; 255(17):2299-305. PubMed ID: 3007791 [TBL] [Abstract][Full Text] [Related]
20. 3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Mitsuya H; Weinhold KJ; Furman PA; St Clair MH; Lehrman SN; Gallo RC; Bolognesi D; Barry DW; Broder S Proc Natl Acad Sci U S A; 1985 Oct; 82(20):7096-100. PubMed ID: 2413459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]